We compared the frequency of MANAscorehi TIL and pTRC in a binary fashion with major pathologic responders (MPR, \documentclass[12pt]{minimal}\usepackage{amsmath}\usepackage{wasysym}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{amsbsy}\usepackage{mathrsfs}\usepackage{upgreek}\setlength{\oddsidemargin}{-69pt}\begin{document}$$\le$$\end{document}≤10% of residual viable tumor cells after anti-PD-1 therapy) vs. non-MPRs, or as a linear function of percent residual viable tumor in 10% increments. Here, PDCD1 is linked to neoplasm.